We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Castlight (CSLT) this Earnings Season?
Read MoreHide Full Article
Castlight Health, Inc. (CSLT - Free Report) is set to report third-quarter 2017 results on Oct 25. Notably, the company has a pretty decent record of earnings surprises with an average positive surprise of 44.5% in the trailing four quarters. Last quarter, the company came up with a positive surprise of 30%.
Loss of 11 cents per share in the second quarter was much narrower than the year-ago loss of 17 cents per share. Revenues increased 36% year over year to $32.1 million and also surpassed the Zacks Consensus Estimate of $31 million. Management noted that increased product launches and higher rate of adoption were the primary growth catalysts.
Growth Catalysts
Castlight’s software platform that assists organizations in gaining control over their health care costs is witnessing rapid adoption. This is evident from the top-line growth of the company. Moreover, the company expects renewals to boost the company’s annualized recurring revenues (ARR).
The Zacks Consensus Estimate for Professional Services segment revenues is around $2.3 million while that for Subscription revenues is about $31.8 million.
The company’s strategic acquisition of Jiff has enhanced its solutions portfolio, thereby improving its customer base via cross-selling of the products. In the third quarter, Castlight added Pickerington School District to its clientele.
Notably, the company’s new mobile application launched in May has also contributed to growth. Additionally, channel partnerships, like the one with Anthem, are also proving to be strong tailwinds Management stated that with a focus on product and packaging execution, demand generation and proper sales and marketing services, “Anthem Engage” is expected to be a key growth driver for the company in the near to long term.
We believe all these factors to be key catalysts for the company’s third-quarter results. The Zacks Consensus Estimate for third-quarter revenues is pegged at $34 million while loss estimates stand at 7 cents per share, indicating a sequential improvement.
The long-term earnings growth rate for Applied Materials, NVIDIA and Vishay Intertechnology is projected to be 17.1%, 10.3% and 20.6% respectively.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
Image: Bigstock
What's in Store for Castlight (CSLT) this Earnings Season?
Castlight Health, Inc. (CSLT - Free Report) is set to report third-quarter 2017 results on Oct 25. Notably, the company has a pretty decent record of earnings surprises with an average positive surprise of 44.5% in the trailing four quarters. Last quarter, the company came up with a positive surprise of 30%.
Loss of 11 cents per share in the second quarter was much narrower than the year-ago loss of 17 cents per share. Revenues increased 36% year over year to $32.1 million and also surpassed the Zacks Consensus Estimate of $31 million. Management noted that increased product launches and higher rate of adoption were the primary growth catalysts.
Growth Catalysts
Castlight’s software platform that assists organizations in gaining control over their health care costs is witnessing rapid adoption. This is evident from the top-line growth of the company. Moreover, the company expects renewals to boost the company’s annualized recurring revenues (ARR).
The Zacks Consensus Estimate for Professional Services segment revenues is around $2.3 million while that for Subscription revenues is about $31.8 million.
The company’s strategic acquisition of Jiff has enhanced its solutions portfolio, thereby improving its customer base via cross-selling of the products. In the third quarter, Castlight added Pickerington School District to its clientele.
Castlight Health, inc. Price and EPS Surprise
Castlight Health, inc. Price and EPS Surprise | Castlight Health, inc. Quote
Notably, the company’s new mobile application launched in May has also contributed to growth. Additionally, channel partnerships, like the one with Anthem, are also proving to be strong tailwinds Management stated that with a focus on product and packaging execution, demand generation and proper sales and marketing services, “Anthem Engage” is expected to be a key growth driver for the company in the near to long term.
We believe all these factors to be key catalysts for the company’s third-quarter results. The Zacks Consensus Estimate for third-quarter revenues is pegged at $34 million while loss estimates stand at 7 cents per share, indicating a sequential improvement.
Zacks Rank & Stocks to Consider
Castlight currently has a Zacks Rank #3 (Hold).
Better-ranked stocks in the broader technology sector include Applied Materials, Inc. (AMAT - Free Report) , NVIDIA Corporation (NVDA - Free Report) and Vishay Intertechnology, Inc. (VSH - Free Report) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The long-term earnings growth rate for Applied Materials, NVIDIA and Vishay Intertechnology is projected to be 17.1%, 10.3% and 20.6% respectively.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.